Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the ...

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Two attempts by Johnson & Johnson to resolve approximately 60,000 talcum powder lawsuits through bankruptcy courts have ...

according to a GoFundMe campaign created by a friend of Johnson’s. He suffered a medical event in his hotel room after his arrival and has been hospitalized since. As of late Monday afternoon ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial public offering as early as this year, Amber Tong ...

We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best cheap stocks to ...

LISI's aerospace segment shows strong growth, while automotive sales decline and medical sales remain flat, leading to a lower price target of $36.38. Read more here.

In the latest trading session, Johnson & Johnson (JNJ ... world's biggest maker of health care products has risen by 0.15% in the past month, leading the Medical sector's loss of 2.46% and ...

Its Innovative Medicine division covers pharmaceuticals focusing on areas like immunology and oncology, alongside MedTech engaging in medical ... products and strategic market expansions. Johnson ...

The Washington Capitals and gaming community has rallied around Wes Johnson, the team's longtime PA announcer and voice actor known for his work in locally-based Bethesda Games video game titles ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to ... Analysts are cautiously optimistic about the pharmaceutical and medical device maker, with six of the 12 analysts ...